STONY BROOK, N.Y., October 15, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit [...]
STONY BROOK, N.Y., January 31, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has entered into securities purchase agreements (SPAs) with certain existing institutional investors (collectively the “Holders”) for the issuance and sale of an aggregate of 5,644,061 of its shares of common [...]
The Specimen Accessioner works closely with Applied DNA Clinical Labs personnel to catalog patient specimens, such as: swab, transport media, body fluids (blood, urine, etc.) or tissue samples, for review. Those samples are processed and examined by laboratory professionals, doctors, and nurses for diagnosis and treatment. Job Duties and Responsibilities Verifies all specimens that [...]
The Diagnostic Sales Account Manager will be responsible for selling the portfolio of existing products and the launch of new products into established and developing markets. They will accomplish this by calling on Public Health Departments, State Department of Health Labs, Reference Laboratories, Hospitals, Infectious Disease Physicians, Pathologists, and all associated stakeholders. [...]
The Diagnostic Sales Account Representative will be responsible for selling the portfolio of existing products into established and developing markets. They will accomplish this by calling on Public Health Departments, State Department of Health Labs, Reference Laboratories, Hospitals, Infectious Disease Physicians, Physicians, Specialists, Pathologists, and all associated stakeholders. Essential Duties and Responsibilities: [...]
STONY BROOK, N.Y. – May 7, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second quarter financial results after market close on Thursday, May 13, 2021. The Company’s management will [...]
STONY BROOK, NY. May 12, 2015. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced results of its second quarter of fiscal 2015. “Our record quarterly revenues contributed to six-month revenues that are greater than any prior full fiscal year. This is an [...]